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Cost/benefit analysis is a technique used by researchers who view themselves as sci-
entific in orientation. However, it is not well understood by many persons who are interested 
in disability studies especially the social impacts of genetic engineering. This lack of under-
standing is regrettable because cost/benefit analysis is simply a type of decision making which 
most people use. 
The literal interpretation of cost/benefit analysis is that a person measures the cost of 
an outcome and the benefits of that outcome. A ratio between the two are calculated dividing 
the cost by the benefit. If the number is greater than one, the costs are more than the benefits 
and presumably that outcome would not be sought. If the number is less than one, the benefits 
outweigh the costs and presumably that outcome would be pursued. 
When a cost/benefit analysis is carried out the ratio is sometimes less than one. Many 
people are not comfortable with this way of expressing the ratio. If costs equal I and benefits 
equal I 2, then the results (I divided by 12) equals 0.08. It was argued that a result less than one 
conveyed a false impression that the benefit of the outcome was very small when actually the 
benefit was (in this example) 12 times the cost. It is said that it is better to express the ratio as 
12 ( 12 divided by 1 ). Consequently, it became customary to do benefit/cost analysis ( dividing 
the benefit by the cost) while still calling it cost/benefit analysis. People must pay attention to 
how the ratio is obtained so as to not be misled. 
A common technique closely related to cost/benefit analysis is cost/effectiveness 
analysis which is simply comparing two cost/benefit analyses. You could calculate two ratios 
and determine that one outcome ( usually a medical procedure) produces a higher number than 
the other. The outcome with the higher number is the preferred one, the most effective proce-
dure. Or you could calculate the net return (benefit minus cost) for the two procedures and say 
that the outcome with the highest net return is the preferred one. In this case the problems are 
only compounded. 
The basis for cost/benefit analysis and related techniques is based upon the defini-
tion of a "rational man" as it is used in economics and in public choice. According to this def-
inition a person calculates the probable benefits of an outcome minus the cost of obtaining that 
outcome. The result is the return for carrying out the action. It is often expressed as R = PB -
C where R is the return, P is the probability of obtaining the benefits if the act is undertaken, 
B those benefits, and C the cost incurred if the act is done. If the return is greater than zero (the 
probably benefits are larger than the cost) and the person performs that act, then the person is 
rational. If the return is zero (the probably benefits equal the cost) or less than zero (the prob-
.able benefits are less than the cost) and the person performs the act, then the person is not act-
ing in a rational manner. 
The world is more complex than this simple scenario as economists and some pub-
lic choice researchers will admit. However, instead of cautioning people about their analysis, 
they simply use Bayseian statistics (the probability that something will occur given the proba-
bility that something else will occur) or other more sophisticated techniques. Since the result 
is usually expressed in dollars (numbers), there is an apparent certainty of the outcome with the 
largest number being the preferred one. 
The problems with cost/benefit analysis and its related techniques are many. First, it 
assumes that the sum of benefits in a society is static, a zero sum game. That is, what someone 
gets another loses. While it is true in many individual cases, it is not true in many other cases 
and it is not true for all of society. Some people give the John Donne argument: the bell tolls 
for everyone, we have a universal dependence on each other.That argument carries only limit-
ed weight. A better argument is that technological advances demonstrably have reduced costs 
and increased benefits over history. However, since the static argument holds in many cases 
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this problem with cost/benefit analysis can be circumvented by its users. For example, it is 
argued that budgets are finite and that there are only a limited amount of benefits in a situation 
and therefore it is a zero sum game. Such an assumption is often obscured in public policy dis-
cussions when it is clearly not correct. ,' 
The second problem concerns data sources. The data bases used in many analyses are 
poor. Often it is estimated data. Sometimes data from one decade is compared with data from 
another decade. The responsible analyst adjusts for these differences, but they can not always 
be reconciled. For example, ifwe use dollars in an analysis, do we use present dollars or future 
dollars discounted in some manner? Ifwe project into the future in regard to savings (or costs), 
do we include interest rates and/or opportunity costs because that dollar can not be used for 
something else? Of course, there are customary ways ofhandling these data questions, but each 
one introduces a bit of uncertainty into the result. 
The third problem involves the measurement of social welfare. The welfare of an 
individual is based upon that person's utility for things in life. The welfare of society is based 
upon the summation of individual utilities. But it is not possible to measure utility in a manner 
so that one person's utility function (how that person values the world) is comparable to anoth-
er person's utility function. In order to sum individual utilities into social welfare, they must be 
measured in the same way. The easy answer for economics and public choice is to translate 
everything into dollars. However, a billionaire may (probably does) have a different amount of 
utility for $100 than a person living in poverty. Economists acknowledge the impossibility of 
comparing different utility functions, but go ahead anyway assuming that everyone has the 
same utility for dollars. So do cost/benefit analysts in genetic engineering even when so many 
variables can not be translated into dollars. 
The fourth problem in cost/benefit analysis concerns the sophisticated techniques 
used. These techniques frequently involve estimates of the mathematical parameters of a set of 
data. There are always confidence intervals around an estimate. That is, if one comes up with 
a result of 25 it may be 25 +/- 15 which means the answer ranges from 10 to 40. Perhaps that 
result is sufficiently precise for the analysis. Perhaps it is not. When joined with the problems 
of imprecise data and measurement of utility, the result may be unintelligible. 
The final problem with cost/benefit analysis is in our culture and not necessarily in 
the technique. People simply believe that a number represents something real. If a researcher 
produces a number which appears to be reasonable, other people tend to accept it. However, 
with problems of data, measurement, and use of estimation procedures the number may be 
meaningless. On the other had, it may not be meaningless, but how do we know if it is? 
In spite of these problems many people make decisions using cost/benefit analysis 
all the time. Although not always certain of the figures, if the relative magnitudes of the costs . 
and the benefits are clear ( one is very large and the other is very small) it is easy to estimate 
the ratio. In other situations the size of the costs and the size of the benefits are not known and 
a decision is avoided. In other cases they are precisely known and the analysis is done. 
In genetics people use cost/benefit analysis often. In the January 1994 issue of 
geneWATCH Paul Billings and Ruth Hubbard discuss a study in Colorado which estimated that 
a-person with Fragile X Syndrome costs the state over a lifetime $1,609,852.63 more than a 
"nonnal" person costs. They do discuss the problems in diagnosis and the eugenic policy impli-
cations of the study. However, the dollar figure is just as specious as the certainty of diagnosis. 
One thing which reveals how ludicrous is the figure is the 63 cents at the end. In no way can 
one be that specific in a cost/benefit analysis over a life time. Variables over a life time can not 
be perfectly predicted and measured. 
Many discussions of the quality of life of a person with a disability rest upon 
cost/benefit analysis. Jack Kevorkian's victims are said to have such a low quality of life that 
they wish to commit suicide. Most non-disabled persons who express a wish to commit suicide 
are given counseling and change their mind. A person with a disability, however, is assumed to 
have a life of very low quality and therefore that person is making a rational, informed deci-
sion to end their tragic life. That is, the cost of continued living far outweigh the benefit. In this 
case it is the negative stereotypes of people with disabilities which cause the measurements of 
both costs and benefits to be skewed. 
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The Oregon Plan for rationing health care is also based upon a quality of life argu-
ment which rests upon a cost/benefit analysis. The social and personal benefits of many dis-
abled persons are estimated to be very low. People can not imagine how persons with disabil-
ities can bear to continue to live. Therefore, the cost of treatment will always outweigh the ben-
efit of living and the treatment should not be provided. 
People who perform studies in economics, in public choice, in genetic engineering, 
and in other areas of decision making must learn the technical side of statistics and data analy-
sis. They must understand the limitations of cost/benefit analysis. Such a result is not a likely 
outcome. Consequently, people who read and who may use these studies must be cautious. 
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